Overview

High Throughput Screening Market is expected to value over USD 25 billion by 2028 end with a CAGR of over 8% during the forecast period 2022-2028.

High-throughput screening (HTS) is a method of discovering new drugs by automated testing of large quantities of chemical and biological compounds against a specific biological target. In the pharmaceutical industry, high-throughput screening methods leverage robotics and automation to rapidly test the biological or biochemical activity of a large number of molecules, usually drugs. In addition to accelerating target analysis, large-scale compound libraries can be cost-effectively screened. In addition to assessing pharmacological targets, HTS is useful for pharmacologically profiling agonists and antagonists for receptors and enzymes (such as GPCRs). Recent advancements in robotics, liquid handling, plate reader detection and high-speed computers have greatly contributed to the modernization of HTS.

High-throughput screening help cut drug development costs. Furthermore, this technique allows for the screening of a large number of compounds utilising high-throughput screening (HTS) up to 10,000 compounds each day, and even 100,000 tests using ultrahigh-throughput screening (UHTS). Robots, detectors, and software are used to control the entire process in this method. It's also used to screen a variety of libraries, including combinatorial chemistry, peptide, genomics, and protein libraries. It's also utilised to characterise novel drug metabolic, pharmacokinetic, and toxicological data. The primary goal of implementing any high-throughput screening technique is to speed up the drug discovery process. High-throughput screening techniques have been widely used in the pharmaceutical and biopharmaceutical industries, and they are useful in integrating automation and robotics equipment to evaluate a large number of samples quickly. This high-throughput screening method allows researchers to swiftly identify active chemicals, antibodies, or genes that influence a certain biomolecular pathway. The findings of these tests can be used to help with medication development and studying the noninteraction or role of a certain region. The global high throughput screening market is expected to rise significantly throughout the forecast period, owing to factors such as growing use of high-throughput screening for drug development, which minimises the time it takes to develop a medicine. Furthermore, the discovery of novel treatments for a variety of life-threatening disorders helps to the high-throughput screening market's growth. 

FutureWise Market Research has instantiated a report that provides an intricate analysis of High Throughput Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the High Throughput Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the High Throughput Screening Market:
• Thermo Fisher Scientific
• Agilent Technologies Inc
• Danaher
• PerkinElmer Inc
• Tecan Group Ltd
• Axxam S.p.A
• Bio-Rad Laboratories Inc
• Merck Group KGaA
• Hamilton Company
• Corning Incorporated
• Biotek Instruments Inc
• Aurora Biomed Inc
(Note: The list of the major players will be updated with the latest market scenario and trends)

High Throughput Screening Market Segmentation:
By Products and Services
• Products
 o Reagents and Assay Kits
 o Instruments
 o Software

• Services
By Technology
• Cell-Based Assays
 o Cell Proliferation Assays 
 o Cell Viability Assays 
 o Cell Cytotoxicity Assays 
 o Cell Death Assays 
 o Other Cell-Based Assays
• Lab-on-a-Chips
 o PDMS
 o Thermopolymers
 o Glass
 o Silicon
 o Paper
• Ultra high throughput Screening 
 o Chip-based Screening 
 o Micro-channel Flow Systems 
 o- Plateless Systems
 o Others
• Label-Free Technology 
 o SPR
 o ITC
 o Others

By Application
• Drug Discovery
 o Medicinal Chemistry
 o Biology Services
 o Drug Metabolism and Pharmacokinetics (DMPK)
• Chemical Biology Programs
 o Cellular & Biological Simulation
 o Disease Modelling 
 o Preclinical Drug Development 
 o Clinical Trials 
• Cell & Organ-Based Screening
 o Drug Discovery 
 o Academic Research 
• Biochemical Screening
 o Blood and Blood –based Products 
 o Vaccines and Therapeutics
 o Stem Cells 
• Biological Active Compound Screening 
 o Target Identification 
 o Primary Screening
 o Toxicology 
• Genomics
 o Diagnostic Application
 o Precision Medicine
• Proteomics
 o Drug Diagnostics
 o Precision Medicine
• Compound Profiling
 o Drug Discovery
 o Cancer/Tumor Profiling 
 o- Toxicology 

By Detection Method
• Mass Spectrometry 
 o Surface-based MALDI-MS
 o LASI-MS Imaging 
 o Injection-based MS
 o Others
• Chromatography 
 o HIC
 o HPLC
 o SEC
 o HPGC
 o Others
• Calorimetry
 o Rapid Mass Calorimeter
 o ITC
 o Nanocalorimetry
 o Array Calorimetry
 o Others
• X-ray Diffraction
 o In situ Crystallization 
 o In meso Crystallization 
 o Crystal X-ray Diffraction 
 o Others

By End-User
•    Pharmaceutical and Biotechnology Companies
•    Academic and Government Institutes
•    Contract Research Organizations (CRO)
•    Others 
   
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

High Throughput Screening Market Sample Video:

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global high throughput screening market by products and services, by technology, by application, by detection method, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions  

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics